Amgen (AMGN) PT Lowered to $317 at UBS
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $439.27 +1.28%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UBS analyst Colin Bristow lowered the price target on Amgen (NASDAQ: AMGN) to $317.00 (from $326.00) while maintaining a Neutral rating.
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Agilent (A) PT Raised to $150 at Jefferies
- Flux Power Holdings (FLUX) PT Lowered to $1.60 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
